{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-151259","form_type":"8-K","ticker":"SLDB","cik":"0001707502","company_name":"Solid Biosciences Inc.","filed_at":"2026-04-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.778486+00:00","generated_at":"2026-05-15T06:41:29.032588+00:00","sec_items":["5.02"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Solid Biosciences reclassifies director Ilan Ganot from Class III to Class I to balance board composition","bullets":["Ilan Ganot resigned from Class III effective 4:00 p.m. ET on April 10, 2026.","Board reduced Class III to three directors and increased Class I to three, appointing Ganot to Class I with term expiring at 2028 Annual Meeting.","Ganot's compensation arrangements unchanged; no compensation due for resignation or appointment.","Company will seek advisory ratification of Ganot's appointment as Class I Director at 2026 Annual Meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-151259","json":"https://secwatch.observer/filing/0001193125-26-151259.json","markdown":"https://secwatch.observer/filing/0001193125-26-151259.md","text":"https://secwatch.observer/filing/0001193125-26-151259.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526151259/0001193125-26-151259-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526151259/sldb-20260410.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T06:41:29.032588+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}